Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study

被引：0
|
作者：
Gabriela Grimaldi
Giuseppe Cancian
Angelica Rizzato
Alex Casanova
Kathrin Perruchoud-Ader
Michele Clerici
Andrea Consigli
Moreno Menghini
机构：
[1] Ente Ospedaliero Cantonale (EOC),Department of Ophthalmology, Institute of Clinical Neurosciences of Southern Switzerland (INSI)
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2024年 / 262卷
关键词：
Faricimab; Age-related macular degeneration; Treat-and-extend; Real-world data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1151 / 1159
页数：8
相关论文
共 50 条
  • [1] Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study
    Grimaldi, Gabriela
    Cancian, Giuseppe
    Rizzato, Angelica
    Casanova, Alex
    Perruchoud-Ader, Kathrin
    Clerici, Michele
    Consigli, Andrea
    Menghini, Moreno
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (04) : 1151 - 1159
  • [2] Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Hang, Abraham
    Ngo, Taylor
    Virk, Jaipreet Singh
    Moussa, Kareem
    Moshiri, Ala
    Emami-Naeini, Parisa
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3781 - 3789
  • [3] One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Cancian, Giuseppe
    Paris, Arianna
    Agliati, Lia
    Rizzato, Angelica
    Clerici, Michele
    Volpe, Giulio
    Menghini, Moreno
    Grimaldi, Gabriela
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (11) : 2985 - 2997
  • [4] Real-world experience of intravitreal faricimab injection in previously treated neovascular age-related macular degeneration eyes: a case series
    Maria A. Bantounou
    Mohammed Elsheikh
    Adelehin Ijasan
    Cynthia Santiago
    BMC Ophthalmology, 25 (1)
  • [5] REAL-WORLD LONG-TERM OUTCOMES OF INTRAVITREAL FARICIMAB IN PREVIOUSLY TREATED CHRONIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Ambati, Naveen R.
    Leone, Adam
    Brill, Daniel
    Sisk, Robert A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2025, 45 (03): : 446 - 453
  • [6] Real -world experience using intravitreal Faricimab for previously treated neovascular age -related macular degeneration
    Ngo, Taylor
    Hang, Abraham
    Virk, Jaipreet
    Moussa, Kareem
    Moshiri, Ala
    Naeini, Parisa Emami
    Yiu, Glenn
    Park, Susanna S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [7] Intravitreal faricimab for treatment naïve patients with neovascular age-related macular degeneration: a real-world prospective study
    Grimaldi, Gabriela
    Cancian, Giuseppe
    Paris, Arianna
    Clerici, Michele
    Volpe, Giulio
    Menghini, Moreno
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [8] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [9] 1-Year real-world outcomes of faricimab in previously treated neovascular age-related macular degeneration
    Janmohamed, Imran Karim
    Mushtaq, Adeel
    Kabbani, Jamil
    Harrow, Simeon
    Nadarajasundaram, Aaruran
    Ata, Anibe
    Monye, Henrietta
    Jarrar, Zakariya
    Hannan, Shabeeba
    Membrey, Luke
    EYE, 2025, : 1344 - 1348
  • [10] Switching intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Kucukerdonmez, Cem
    Gelisken, Faik
    Yoeruek, Efdal
    Bartz-Schmidt, Karl Ulrich
    Leitritz, Martin Alexander
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (01) : 51 - 56
12345